EE254 Analysis of Path of Therapy in the Treatment of Spasticity in Adult Post-Stroke Patients

Abstract

Post-stroke spasticity (PSS), a common sequela of stroke, occurs in ∼25-43% of patients between 2 weeks-3 months following a stroke. Treatment guidelines recommend botulinum toxin-A (BoNT-A) as first-line treatment for management of PSS based on the most robust evidence (level A). We examined pharmacological treatment patterns for spasticity following hospitalization post-stroke in adults over a 2-year follow-up period.